These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11175636)

  • 1. Cyclin D1 expression in dysplastic nevi: an immunohistochemical study.
    Ewanowich C; Brynes RK; Medeiros L; McCourty A; Lai R
    Arch Pathol Lab Med; 2001 Feb; 125(2):208-10. PubMed ID: 11175636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 overexpression in Spitz nevi: an immunohistochemical study.
    Nagasaka T; Lai R; Medeiros LJ; Brynes RK; McCourty A; Harada T; Saddik M
    Am J Dermatopathol; 1999 Apr; 21(2):115-20. PubMed ID: 10218669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 and D3 expression in melanocytic skin lesions.
    Alekseenko A; Wojas-Pelc A; Lis GJ; Furgał-Borzych A; Surówka G; Litwin JA
    Arch Dermatol Res; 2010 Sep; 302(7):545-50. PubMed ID: 20496072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of Ki-67 proliferative index and cyclin D1 expression of dysplastic nevi in the biologic spectrum of melanocytic lesions.
    Lebe B; Pabuççuoğlu U; Ozer E
    Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):160-4. PubMed ID: 17525627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.
    Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ
    Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular aspects of melanocytic dysplastic nevi.
    Hussein MR; Wood GS
    J Mol Diagn; 2002 May; 4(2):71-80. PubMed ID: 11986397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle analysis can differentiate thin melanomas from dysplastic nevi and reveals accelerated replication in thick melanomas.
    Kiszner G; Wichmann B; Nemeth IB; Varga E; Meggyeshazi N; Teleki I; Balla P; Maros ME; Penksza K; Krenacs T
    Virchows Arch; 2014 May; 464(5):603-12. PubMed ID: 24682564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grade of atypia in dysplastic nevi and relationship with dermal fibroplasia.
    Babacan A; Lebe B
    Turk Patoloji Derg; 2012; 28(1):17-23. PubMed ID: 22207427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of reflectance confocal microscopy in differentiating melanoma in situ from dysplastic nevi with severe atypia: A cross-sectional study.
    Fraga-Braghiroli N; Grant-Kels JM; Oliviero M; Rabinovitz H; Ferenczi K; Scope A
    J Am Acad Dermatol; 2020 Oct; 83(4):1035-1043. PubMed ID: 32442695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMB-45 staining of dysplastic nevi. Support for a spectrum of progression toward melanoma.
    Smoller BR; McNutt NS; Hsu A
    Am J Surg Pathol; 1989 Aug; 13(8):680-4. PubMed ID: 2473661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS; Shakhtour B; Shyr Y
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14).
    Pruneri G; Fabris S; Baldini L; Carboni N; Zagano S; Colombi MA; Ciceri G; Lombardi L; Rocchi M; Buffa R; Maiolo AT; Neri A
    Am J Pathol; 2000 May; 156(5):1505-13. PubMed ID: 10793062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of ROC1 protein in the control of cyclin D1 protein expression in skin melanomas.
    Nai G; Marques M
    Pathol Res Pract; 2011 Mar; 207(3):174-81. PubMed ID: 21300445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle and apoptosis regulators in Spitz nevi: comparison with melanomas and common nevi.
    Stefanaki C; Stefanaki K; Antoniou C; Argyrakos T; Patereli A; Stratigos A; Katsambas A
    J Am Acad Dermatol; 2007 May; 56(5):815-24. PubMed ID: 17437889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue.
    Fullen DR; Zhu W; Thomas D; Su LD
    J Cutan Pathol; 2005 Nov; 32(10):680-4. PubMed ID: 16293180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IMP-3 EXPRESSION IN BENIGN MELANOCYTIC NEVI, DYSPLASTIC NEVI AND MALIGNANT MELANOMA: PRELIMINARY FINDINGS IN BULGARIAN PATIENTS.
    Chokoeva AA; Ananiev J; Wollina U; Tana C; Lotti T; Cardoso JC; Tchernev G
    J Biol Regul Homeost Agents; 2015; 29(3):695-9. PubMed ID: 26403409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanocytic lesions in a private pathology practice. Comparison of histologic features in different tumor types with particular reference to dysplastic nevi.
    Hastrup N; Hou-Jensen K
    APMIS; 1993 Nov; 101(11):845-50. PubMed ID: 8286092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of VEGF, HIF1-a, and PlGF in malignant melanomas and dysplastic nevi.
    Konstantina A; Lazaris AC; Ioannidis E; Liossi A; Aroni K
    Melanoma Res; 2011 Oct; 21(5):389-94. PubMed ID: 21876459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of DNA ploidy in dysplastic and Spitz nevi by flow cytometry.
    Winokur TS; Palazzo JP; Johnson WC; Duray PH
    J Cutan Pathol; 1990 Dec; 17(6):342-7. PubMed ID: 2074280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different patterns of expression of the erbB family of receptor tyrosine kinases in common nevi, dysplastic nevi, and primary malignant melanomas: an immunohistochemical study.
    Feinmesser M; Veltman V; Morgenstern S; Tobar A; Gutman H; Kaganovsky E; Tzabari C; Sulkes J; Okon E
    Am J Dermatopathol; 2010 Oct; 32(7):665-75. PubMed ID: 20559114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.